Kineta Inc. (NASDAQ: KA)
$0.71
-0.0225 ( -3.08% ) 92.5K
Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.
Market Data
Open
$0.71
Previous close
$0.73
Volume
92.5K
Market cap
$8.70M
Day range
$0.71 - $0.79
52 week range
$0.33 - $5.39
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 50 | Jan 05, 2024 |
| 8-k | 8K-related | 13 | Dec 15, 2023 |
| 4 | Insider transactions | 1 | Dec 06, 2023 |
| 4 | Insider transactions | 1 | Nov 30, 2023 |
| 4 | Insider transactions | 1 | Nov 30, 2023 |
| 8-k | 8K-related | 52 | Nov 06, 2023 |
| 10-q | Quarterly Reports | 85 | Nov 03, 2023 |
| 8-k | 8K-related | 14 | Nov 03, 2023 |
| 8-k | 8K-related | 14 | Nov 03, 2023 |
| 8-k | 8K-related | 48 | Oct 17, 2023 |